Aggressive Beta-Lactam PK/PD Targets in Gram-Negative Infection Treatment Improve Critically Ill Outcomes
The following is a summary of “Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis,” published in...